5
Total deals
$3.1B
Total value
$1.6B
Avg deal
$1.9B
Largest
| # | Acquired | Date | Type | Status | Price | |
|---|---|---|---|---|---|---|
| 1 |
KalVista Pharmaceuticals
KalVista Pharmaceuticals focuses on developing oral medicines, particularly for …
|
2026-04-29 | Acquisition | Pending | $1.9B | Deal → |
| 2 |
Amryt Pharma
Amryt Pharma creates and delivers innovative treatments to help patients with ra…
|
2023-01-08 | Acquisition | Complete | $1.2B | Deal → |
| 3 |
Atopix Therapeutics
Atopix Therapeutics Limited is a privately held, clinical-stage, biopharmaceutic…
|
2016-11-21 | Acquisition | Complete | — | Deal → |
| 4 |
Cornerstone Therapeutics
Cornerstone Therapeutics is a pharmaceutical company focused on developing and c…
|
2014-02-04 | Acquisition | Complete | — | Deal → |
| 5 |
Zymenex
Zymenex is a Scandinavian biopharmaceutical company focused on the development a…
|
2013-08-26 | Acquisition | Complete | — | Deal → |